What is FemTech AI?
TL;DR
AI for women's health (cycle/fertility/pregnancy/menopause). Flo/Clue/Natural Cycles/Maven Clinic deliver +30% cycle prediction accuracy, +25% fertility treatment success, -30% workplace attrition. 500M cumulative users, market $60B by 2030 (18% CAGR).
FemTech AI: Definition & Explanation
FemTech AI refers to AI (ML/Computer Vision/sensor/wearable integration) supporting women's specific health concerns (cycle, fertility, contraception, pregnancy, postpartum, menopause, PCOS, endometriosis, breast cancer). Per Grand View Research, the FemTech market grows from $22B (2024) to $60B (2030, 18% CAGR), 78% of US women use a FemTech app by 2026, $3.5B cumulative investment in 2024 (women founders +75%), Flo 300M downloads, Clue 150M, Natural Cycles 3M, Apple Watch Cycle Tracking 60% of female US iPhone users. Leading platforms: (1) Flo Health (UK unicorn $1B, 300M downloads, cycle/fertility/pregnancy/menopause integrated, Anonymous Mode), (2) Clue (Germany BioWink, 150M, joint with women's medical research institutes, FDA-cleared Clue Birth Control 2021), (3) Natural Cycles (Sweden, 3M, world's first FDA-cleared AI contraception 2018, basal temp + AI, Oura integration), (4) Glow (US, 15M, fertility-focused, IVF Track), (5) Ovia Health (US, 8M, Walmart/Caesars/Activision adoption, Labcorp subsidiary), (6) Apple Health Cycle Tracking (Apple Watch Series 8+ temperature sensor, 200M, on-device), (7) Oura Ring Gen 4 (Finland, 2.5M, temp/HRV AI, Natural Cycles integration), (8) WHOOP 5.0 (US, 2M, female Strain/Recovery, medical-grade, elite female athletes), (9) Maven Clinic (US unicorn $1.4B, 17M, Microsoft/Bank of America/Walmart, employer benefit $100-300/mo), (10) Tia (US, $160M raised, women's full-service clinic, NY/LA/SF/Chicago/Phoenix), (11) Caria (US, $3M, menopause-focused, HRT AI), (12) Midi Health (US, $60M, menopause Telehealth), (13) Allara Health (US, $15M, PCOS dx), (14) Hertility (UK, women's hormone testing DTC), (15) Carrot Fertility (US, employer IVF benefit $25K-150K/employee). Key use cases: (I) Cycle prediction (Flo/Clue — AI 90%+ accuracy, 500M users), (II) FDA natural contraception (Natural Cycles/Clue BC — Perfect Use 98% / Typical 93%), (III) Fertility / ovulation tracking (Glow/Ovia/Flo TTC — 1M+ pregnancies), (IV) Pregnancy management / weekly guide (Ovia/Flo/Glow Nurture — complication AI prediction), (V) Menopause symptom management (Flo Menopause/Caria/Elektra/Midi — 50M US women market, HRT AI), (VI) PCOS / endometriosis dx support (Allara/Hertility — 7-yr → 1-yr delay reduction, 5M US PCOS patients), (VII) Fertility IVF optimization (Maven/Carrot/Progyny NASDAQ:PGNY — cycle prediction, AI embryo grading), (VIII) Postpartum / mental health (Maven/Cleo/Peanut — postpartum depression screening), (IX) AI breast cancer screening (iCAD/Volpara/Lunit — +25% detection accuracy), (X) Pelvic floor training / sex ed (Elvie $97M / Joylux — postpartum rehab). ROI by deployer: (A) Individual (free-$15/mo) = Flo + Apple Cycle Tracking + Natural Cycles $10 = $10/mo, $500-2000/yr clinic visit savings; (B) Fertility couple ($300-1000/mo) = Glow Premium + Maven + IVF Clinic, +25% success / -30% cycles, save $10-50K; (C) Menopause working woman ($50-200/mo) = Flo Menopause + Caria + Maven, productivity recovery $5-10K/yr; (D) 1K-employee employer ($300K-1M/yr) = Maven + Carrot + Ovia employer, female attrition -30%, recruitment $5M savings, 10-20x ROI; (E) Large enterprise 10K+ ($3-10M/yr) = Maven + Carrot + Progyny + Equip + Cleo, female mgmt +15% / attrition -30%, 5-15x ROI. Validation: Flo 300M downloads, Clue 150M, Natural Cycles 3M, Maven 17M, Apple Cycle Tracking 60% of female US iPhone users. Cycle prediction calendar 60% → AI 90%+, Natural Cycles Perfect Use 98%, Maven employer female attrition -30%, Progyny IVF +25%, Lunit breast cancer AI +25%, iCAD radiologist -30% time. Ethical guardrails: (★) Menstrual data privacy / state subpoena (post-Roe 2022, 14 states banned abortion, Anonymous Mode/on-device/EU GDPR-based/E2E encryption/Privacy by Design); (★) Medical misinformation / non-FDA (only FDA-cleared for contraception, MD consultation recommended, medical liability insurance); (★) Data bias / race / age / LGBTQ+ underrepresentation (diverse training data Clue leads, trans-inclusive Clue Plus 2023, per-race accuracy publication); (★) Over-commercialization / exaggeration (FTC misrepresentation, "Wellness/Tracking only" labels, FDA Statement compliance, #ad/#sponsored); (★) Benefit pretense / workplace harassment (Maven Confidentiality Wall, EEOC Pregnancy Discrimination Act, female-mgmt-ratio KPI publication). 2026 trends: (★) Agentic Health Coach (Anthropic Computer Use API — AI doula 24/7, symptoms → MD → Rx autonomous, Maven leads); (★) CGM × hormones (Dexcom/Abbott Libre + cycle, PCOS AI, Levels Health $100M); (★) Hormone-as-a-Service DTC (Modern Fertility/Mira/Inito, AI interpretation, $10B 2030); (★) Menopause Tech explosive growth (Caria/Elektra/Midi/Evernow, HRT AI, 50M US women, $500M raised); (★) AI Maternal Mortality Prevention (US CDC Black women 3x mortality, Mayo Clinic Vivacity/Maven, $2-5B); (★) Fertility Preservation / Egg Freezing AI (around-35 boom, Kindbody/Spring Fertility/Carrot, Apple/Meta $10-25K benefit); (★) LGBTQ+ Inclusive Reproductive Health (trans cycle tracking, Folx Health/Plume/Pride Counseling, $200M raised); (★) AI Wearable integration (Apple Watch Series 9+, Oura Gen 4, WHOOP MG women's mode); (★) Pregnancy Risk Prediction AI (Mayo Clinic/Mt. Sinai integration); (★) AI Lactation Support (Elvie/Willow pump IoT, return-to-work). Roadmap: Month 1-3 Flo/Apple Cycle Tracking individual trial; Month 4-6 Maven employer benefit; Month 7-12 Carrot/Progyny IVF; Year 2 Menopause Tech integration; Year 3 Agentic Health Coach + CGM.